Portfolio (Quarterly)
Guide ↗
Deep Track Capital, LP
· CIK 0001856083| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GH | GUARDANT HEALTH INC | Healthcare | 3,393,312.0 | $509.1M | 7.41% | NEW | — | $150.03 | +7.7% |
| 2 | IMVT | IMMUNOVANT INC | Healthcare | 9,341,151.0 | $359.9M | 5.24% | NEW | — | $38.53 | +13.4% |
| 3 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 4,740,072.0 | $254.4M | 3.70% | NEW | — | $53.67 | -1.9% |
| 4 | PCVX | VAXCYTE INC | Healthcare | 4,300,000.0 | $250.0M | 3.64% | NEW | — | $58.13 | +3.6% |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 825,000.0 | $248.3M | 3.62% | NEW | — | $301.03 | -23.6% |
| 6 | MANE | VERADERMICS INC | Healthcare | 2,000,000.0 | $245.9M | 3.58% | NEW | — | $122.94 | -12.1% |
| 7 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 3,666,768.0 | $230.8M | 3.36% | NEW | — | $62.94 | +11.8% |
| 8 | NUVL | NUVALENT INC | Healthcare | 1,783,322.0 | $220.2M | 3.21% | NEW | — | $123.50 | +0.4% |
| 9 | ALKS | ALKERMES PLC | Healthcare | 4,000,000.0 | $209.6M | 3.05% | NEW | — | $52.40 | -4.8% |
| 10 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 19,686,282.0 | $193.3M | 2.81% | NEW | — | $9.82 | +8.6% |
| 11 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 3,307,481.0 | $189.3M | 2.75% | NEW | — | $57.22 | +19.1% |
| 12 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 7,736,455.0 | $187.7M | 2.73% | NEW | — | $24.26 | +10.8% |
| 13 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 1,926,000.0 | $183.3M | 2.67% | NEW | — | $95.17 | +17.5% |
| 14 | ALMS | ALUMIS INC | Healthcare | 6,348,558.0 | $178.6M | 2.60% | NEW | — | $28.14 | -13.0% |
| 15 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 2,200,000.0 | $174.4M | 2.54% | NEW | — | $79.29 | -24.8% |
| 16 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 12,161,496.0 | $172.1M | 2.50% | NEW | — | $14.15 | -5.8% |
| 17 | VERA | VERA THERAPEUTICS INC | Healthcare | 4,000,000.0 | $171.6M | 2.50% | NEW | — | $42.91 | -25.9% |
| 18 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 700,000.0 | $171.3M | 2.49% | NEW | — | $244.77 | -11.5% |
| 19 | GMAB | GENMAB A/S | Healthcare | 5,650,000.0 | $155.2M | 2.26% | NEW | — | $27.47 | +19.3% |
| 20 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 6,999,025.0 | $136.3M | 1.98% | NEW | — | $19.47 | -16.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Financial Services
0.4%